Cryoport, Inc. Share Price

Equities

CYRX

US2290503075

Air Freight & Logistics

Market Closed - Nasdaq 21:00:00 24/05/2024 BST 5-day change 1st Jan Change
11.04 USD +1.85% Intraday chart for Cryoport, Inc. -12.73% -28.73%
Sales 2024 * 243M 19.05B Sales 2025 * 266M 20.86B Capitalization 544M 42.7B
Net income 2024 * -68M -5.34B Net income 2025 * -55M -4.32B EV / Sales 2024 * 2.35 x
Net Debt 2024 * 26.51M 2.08B Net Debt 2025 * 52.1M 4.09B EV / Sales 2025 * 2.24 x
P/E ratio 2024 *
-7.84 x
P/E ratio 2025 *
-9.96 x
Employees 1,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.44%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.85%
1 week-12.73%
Current month-31.81%
1 month-31.13%
3 months-30.21%
6 months-24.90%
Current year-28.73%
More quotes
1 week
10.76
Extreme 10.76
12.58
1 month
10.76
Extreme 10.76
17.41
Current year
10.76
Extreme 10.76
20.11
1 year
9.00
Extreme 9
23.50
3 years
9.00
Extreme 9
86.30
5 years
9.00
Extreme 9
86.30
10 years
1.03
Extreme 1.0301
86.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 76 21/10/12
Director of Finance/CFO 59 26/06/11
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 81 31/12/14
Director/Board Member 65 14/03/21
Chief Executive Officer 76 21/10/12
More insiders
Date Price Change Volume
24/05/24 11.04 +1.85% 426,632
23/05/24 10.84 -5.90% 408,496
22/05/24 11.52 -3.11% 261,313
21/05/24 11.89 +0.17% 484,455
20/05/24 11.87 -6.17% 435,546

Delayed Quote Nasdaq, May 24, 2024 at 09:00 pm

More quotes
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
11.04 USD
Average target price
17.89 USD
Spread / Average Target
+62.04%
Consensus